Co-Diagnostics, Inc. (CODX) vs Enlivex Therapeutics Ltd. (ENLV)
A side-by-side comparison of Co-Diagnostics, Inc. and Enlivex Therapeutics Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CODX
Co-Diagnostics, Inc.
$1.14HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT
ENLV
Enlivex Therapeutics Ltd.
$0.35HealthcareDelayed quote: Oct 6, 2026, 1:53 PM EDT
Total return — CODX vs ENLV
growth of $100 · dividends reinvested · last 9yCODX -99.4% (-43.0%/yr)ENLV -99.9% (-53.0%/yr)CODX compounded faster over this window
Log scale — wide-divergence pair
CODX ENLV
CODX vs ENLV: by the numbers
- •CODX is the larger company ($7M vs $6M market cap).
- •Both run net losses; ENLV's is the smaller (0.00% vs -6523.04% net margin).
Metrics side by side
Valuation
| Metric | CODX | ENLV |
|---|---|---|
| P/E ratio | N/A | 0.00 |
| P/S ratio | 9.88 | N/A |
| P/B ratio | 0.56 | 0.00 |
Profitability
| Metric | CODX | ENLV |
|---|---|---|
| Gross margin | 64.28% | 0.00% |
| Operating margin | -5025.53% | 0.00% |
| Net margin | -6523.04% | 0.00% |
| ROE | -370.16% | 105.35% |
| ROIC | -219.15% | -0.32% |
Growth (annualized)
| Metric | CODX | ENLV |
|---|---|---|
| Revenue CAGR (5Y) | -62.43% | N/A |
| Total return CAGR (5Y) | -66.53% | -69.81% |
Frequently asked
- How have CODX and ENLV total returns compared?
- Over the past 5 years, CODX delivered -66.53% and ENLV delivered -69.81% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Co-Diagnostics ROEEnlivex Therapeutics ROECo-Diagnostics operating marginEnlivex Therapeutics operating marginCo-Diagnostics revenue growthEnlivex Therapeutics revenue growthCo-Diagnostics free cash flowEnlivex Therapeutics free cash flow
Co-Diagnostics & Enlivex Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.